Abstract

AbstractStudy Finds New Transdermal Rivastigmine Patch may be Optimal way to Deliver TreatmentPramipexole as Adjunctive Treatment in African, Asian and Hispanic Parkinson's Disease PatientsEarly Onset Tardive Dyskinesia Possibly Induced by OlanzapineProlonged Release 24‐Hour Ropinirole Reduces “off” Time in Parkinson'sCaregivers Prefer Rivastigmine Patch Over CapsulePharmacokinetic SubstudyExperimental Drug Pristiq Effective in Low Doses Against Hot Flashes and DepressionLong‐Term Escitalopram Treatment of Major Depression in the ElderlyValproic Acid‐Induced Cognitive Impairment in an Elderly ManPergolide Withdrawn from the Market

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.